1. Body composition as a predictor of chemotherapy toxicity in patients with metastatic prostate cancer treated with docetaxel. (11th September 2015) Authors: Cushen, S.J.; Power, D.G.; McDermot, R.; O'Sullivan, K.; Maceneaney, P.; Daly, L.; Ryan, A.M. Journal: Proceedings of the Nutrition Society Issue: Volume 74(2015):Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Body composition as a predictor of chemotherapy toxicity in patients with metastatic prostate cancer treated with docetaxel. (22nd April 2015) Authors: Cushen, S. J.; Power, D. G.; McDermot, R.; O'Sullivan, K.; Maceneaney, P.; Daly, L.; Ryan, A. M. Journal: Proceedings of the Nutrition Society Issue: Volume 74(2015)Supplement OCE2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗